by Henry Khederian | Jul 10, 2026 | General
ServiceNow Inc. (NYSE:NOW) shares are trading lower by almost 2% on Friday as investors continue to digest fresh AI partnership headlines. ServiceNow stock is facing resistance. Why is NOW stock retreating? What Is Driving ServiceNow’s Stock Today? The latest...
by Henry Khederian | Jul 10, 2026 | General
Lucid Group Inc (NASDAQ:LCID) shares are trading lower by more than 4% on Friday as investors digest a fresh set of execution updates and leadership changes. Lucid Group shares are sliding. Why is LCID stock falling? What To Watch For Lucid Group’s Next Earnings The...
by Erica Kollmann | Jul 10, 2026 | General
Rackspace Technology Inc. (NASDAQ:RXT) is moving the conversation away from raw GPU capacity and toward who actually owns the AI outcomes those chips enable. RXT stock is climbing. See the real-time price action here. In an exclusive interview with Benzinga, CFO Mark...
by Vandana Singh | Jul 10, 2026 | General
The U.S. Food and Drug Administration (FDA) on Friday approved Sanofi SA’s (NASDAQ:SNY) subcutaneous Sarclisa Escena (isatuximab-irfc) in combination with standard-of-care regimens for multiple myeloma across all approved indications of the intravenous formulation....
by Caroline Ryan | Jul 10, 2026 | General
New On The Block Critical Metals Corp. (NASDAQ:CRML) launched a strategic review of non-core assets as it shifts its focus toward developing the Tanbreez rare earth project in Greenland. The company hired Clear Street to evaluate options, including asset sales, joint...
by Vandana Singh | Jul 10, 2026 | General
On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE:PFE) and Astellas Pharma Inc.’s (OTC:ALPMF) (OTC:ALPMY) PADCEV (enfortumab vedotin-ejfv) combo regimen for bladder cancer. The approval covers PADCEV in combination with Keytruda...
Recent Comments